Abbrea Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $359K | Sell |
4,519
-558
| -11% | -$45.7K | 0.05% | 182 |
|
|
2024
Q1 | $446K | Buy |
5,077
+125
| +3% | +$10.7K | 0.06% | 175 |
|
|
2023
Q4 | $411K | Sell |
4,952
-1,230
| -20% | -$93.7K | 0.06% | 172 |
|
|
2023
Q3 | $489K | Sell |
6,182
-45
| -0.7% | -$3.77K | 0.08% | 154 |
|
|
2023
Q2 | $553K | Buy |
6,227
+551
| +10% | +$47.4K | 0.09% | 150 |
|
|
2023
Q1 | $461K | Buy |
5,676
+643
| +13% | +$52.4K | 0.08% | 161 |
|
|
2022
Q4 | $395K | Sell |
5,033
-1,270
| -20% | -$103K | 0.07% | 166 |
|
|
2022
Q3 | $513K | Sell |
6,303
-329
| -5% | -$29.6K | 0.1% | 142 |
|
|
2022
Q2 | $600K | Buy |
6,632
+112
| +2% | +$11.3K | 0.1% | 145 |
|
|
2022
Q1 | $728K | Buy |
6,520
+395
| +6% | +$41.7K | 0.1% | 149 |
|
|
2021
Q4 | $637K | Sell |
6,125
-340
| -5% | -$39.4K | 0.09% | 154 |
|
|
2021
Q3 | $814K | Sell |
6,465
-160
| -2% | -$20.7K | 0.12% | 131 |
|
|
2021
Q2 | $827K | Sell |
6,625
-84
| -1% | -$10.5K | 0.12% | 129 |
|
|
2021
Q1 | $796K | Buy |
6,709
+94
| +1% | +$11K | 0.13% | 122 |
|
|
2020
Q4 | $779K | Buy |
6,615
+400
| +6% | +$44K | 0.14% | 113 |
|
|
2020
Q3 | $649K | Sell |
6,215
-317
| -5% | -$31.8K | 0.14% | 114 |
|
|
2020
Q2 | $603K | Sell |
6,532
-273
| -4% | -$26.2K | 0.14% | 121 |
|
|
2020
Q1 | $617K | Sell |
6,805
-285
| -4% | -$30.3K | 0.16% | 109 |
|
|
2019
Q4 | $808K | Buy |
7,090
+290
| +4% | +$31.8K | 0.17% | 113 |
|
|
2019
Q3 | $742K | Buy |
6,800
+690
| +11% | +$72K | 0.17% | 115 |
|
|
2019
Q2 | $595K | Buy |
6,110
+1,771
| +41% | +$162K | 0.15% | 123 |
|
|
2019
Q1 | $397K | Sell |
4,339
-45
| -1% | -$4.03K | 0.11% | 124 |
|
|
2018
Q4 | $401K | Buy |
4,384
+128
| +3% | +$12K | 0.13% | 117 |
|
|
2018
Q3 | $421K | Buy |
4,256
+220
| +5% | +$20.3K | 0.12% | 124 |
|
|
2018
Q2 | $346K | Buy |
4,036
+120
| +3% | +$10K | 0.11% | 133 |
|
|
2018
Q1 | $316K | Buy |
3,916
+238
| +6% | +$19.6K | 0.1% | 139 |
|
|
2017
Q4 | $299K | Sell |
3,678
-41
| -1% | -$3.28K | 0.1% | 134 |
|
|
2017
Q3 | $291K | Buy |
3,719
+55
| +2% | +$4.57K | 0.11% | 132 |
|
|
2017
Q2 | $325K | Buy |
3,664
+195
| +6% | +$16.4K | 0.13% | 122 |
|
|
2017
Q1 | $281K | Buy |
3,469
+45
| +1% | +$3.52K | 0.11% | 126 |
|
|
2016
Q4 | $244K | Buy |
+3,424
| New | +$269K | 0.11% | 125 |
|
Other funds holding MDT
Abbrea Capital's MDT Position: Q2 2024 in Review
Abbrea Capital reduced its Medtronic (MDT) stake by 11% in Q2 2024, selling an estimated $45.7K and leaving 4,519 shares worth $359K. The position accounts for 0.05% of the portfolio, ranked #182.
Abbrea Capital first reported a position in MDT in Q4 2016 and has held it in 31 quarters since. The position peaked at $827K in Q2 2021. 2,024 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Abbrea Capital held 4,519 shares of Medtronic worth $359K as of Q2 2024.
- Abbrea Capital sold 558 Medtronic shares in Q2 2024, an estimated $45.7K.
- Medtronic made up 0.05% of Abbrea Capital's portfolio in Q2 2024, its #182 holding.
- Abbrea Capital first reported a position in Medtronic in Q4 2016 and has held it in 31 quarters since.
- Abbrea Capital's Medtronic position peaked at $827K in Q2 2021.
- 2,024 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.